Download PDF
Semin Respir Crit Care Med
DOI: 10.1055/a-2691-6206
Review Article

Factors Influencing Glucocorticoid Treatment Response: Mechanism-Based Strategies to Overcome Glucocorticoid Resistance and Restore GRα Function

Authors

  • G. Umberto Meduri

    1   Department of Medicine and Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, United States
Further Information
   Permissions and Reprints
Preview

Abstract

Glucocorticoids (GCs) remain central to managing dysregulated systemic inflammation in critical illness, yet therapeutic response varies widely due to multifactorial glucocorticoid resistance (GCR). This chapter provides a translational framework to guide clinicians in identifying and overcoming GCR, with a central emphasis on restoring glucocorticoid receptor α (GRα) function. Mechanisms of resistance include reduced GRα expression, GRβ dominance, impaired nuclear translocation, oxidative stress, mitochondrial dysfunction, micronutrient depletion, and epigenetic suppression. Pharmacokinetic and pharmacodynamic barriers—such as suboptimal dosing, impaired tissue penetration, accelerated clearance, erratic dosing schedules, and premature tapering—further compromise GRα engagement and treatment efficacy. In addition, interindividual variability in GR responsiveness is shaped by genetic polymorphisms, isoform balance, and local tissue conditions, compounded by up to 10-fold variability in circulating drug levels within the same patient. This chapter outlines evidence-based strategies to optimize GC therapy, including dose refinement, continuous infusion protocols, biomarker-guided escalation, and structured tapering. Adjunctive therapies—such as antioxidants, micronutrients, probiotics, and melatonin—are also highlighted for their role in enhancing mitochondrial resilience, redox stability, and GRα signaling across key regulatory phases. Importantly, many of these disruptions—whether arising from mitochondrial dysfunction, epigenetic changes, or intestinal dysbiosis—converge on shared molecular pathways such as nuclear factor kappa-B (NF-κB) activation, mitogen-activated protein kinase (MAPK) signaling, histone deacetylase 2 (HDAC2) inhibition, and oxidative stress, all of which compromise GRα function across systems. Recognizing this mechanistic convergence helps explain the multisystem nature of steroid resistance. It supports a unified therapeutic approach that targets oxidative stress, restores mitochondrial function, modulates the microbiome, and reinforces epigenetic regulation—working together to preserve GRα signaling across affected systems. While this framework is grounded in mechanistic and translational evidence, its application in clinical practice—including tapering strategies, biomarker thresholds, and adjunctive therapies—requires validation in randomized controlled trials.

Keywords

critical illness - glucocorticoid receptor-α - glucocorticoid resistance - homeostatic correction - mitochondrial dysfunction - systemic inflammation

Note

A comprehensive literature review was conducted using the Consensus database and Google Scholar to identify relevant articles published between 1995 and 2025. Manual screening of references from key review articles and clinical guidelines was also performed to ensure completeness and relevance to this translational synthesis.




Publication History

Received: 30 April 2025

Accepted: 28 August 2025

Accepted Manuscript online:
28 August 2025

Article published online:
16 September 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA